[1]
H. Gamborg, RN, J. Riis, RN, L. Christrup, MSc (Pharm), PhD, and T. Krantz, MD, “Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases”, J of Opioid Management, vol. 9, no. 4, pp. 269–274, Jul. 2013.